This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0004054142 Reproduction Date:
A dopamine agonist is a compound that activates dopamine receptors in the absence of that receptor's physiological ligand, the neurotransmitter dopamine. Dopamine agonists activate signaling pathways through the dopamine receptor and trimeric G-proteins, ultimately leading to changes in gene transcription.
Some medical drugs act as dopamine agonists and can treat hypodopaminergic (low dopamine) conditions; they are typically used for treating Parkinson's disease, attention deficit/hyperactivity disorder (in the form of stimulants) and certain pituitary tumors (prolactinoma), and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA-approved for the treatment of RLS. There is also an ongoing clinical trial to test the effectiveness of the dopamine agonist Requip (ropinirole) in reversing the symptoms of SSRI-induced sexual dysfunction and Post-SSRI sexual dysfunction (PSSD).[1] Additionally, a systematic review and meta-analysis concluded that prophylactic treatment with cabergoline reduces the incidence, but not the severity, of ovarian hyperstimulation syndrome (OHSS), without compromising pregnancy outcomes, in females undergoing stimulated cycles of in vitro fertilization (IVF).[2]
Some of the common side effects of dopamine agonists include:[3][4]
Examples of dopamine agonists include:
Some, such as fenoldopam, are selective for dopamine receptor D1.[7]
6. Avanzi M, Uber E, Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease. Neurol Sci 2004; 25:98–101[Medline]
Muhammad Ali, Alzheimer's disease, Pathology, Dementia, Alpha-synuclein
Methamphetamine, Addiction, Norepinephrine, Gene expression, PubChem
Amphetamine, Methamphetamine, Digital object identifier, Schizophrenia, Μ-opioid receptor
United States National Library of Medicine, Psychology, Medical classification, Psychiatry, Anthropology
Amphetamine, Methamphetamine, Carbon, Hydrogen, Nitrogen
Eli Lilly and Company, Johnson & Johnson, Procter & Gamble, Parkinson's disease, Abbott Laboratories
Amphetamine, Carbon, Hydrogen, Nitrogen, Oxygen